Week-12 response to therapy as a predictor of week 24, 48, and 96 outcome in patients receiving the HIV fusion inhibitor enfuvirtide in the T-20 versus Optimized Regimen Only (TORO) trials (Q46943806)
Jump to navigation
Jump to search
scientific article published in February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Week-12 response to therapy as a predictor of week 24, 48, and 96 outcome in patients receiving the HIV fusion inhibitor enfuvirtide in the T-20 versus Optimized Regimen Only (TORO) trials |
scientific article published in February 2006 |
Statements
1 reference
Week-12 response to therapy as a predictor of week 24, 48, and 96 outcome in patients receiving the HIV fusion inhibitor enfuvirtide in the T-20 versus Optimized Regimen Only (TORO) trials (English)
1 reference
Christine Katlama
1 reference
Michael Saag
1 reference
Francois Raffi
1 reference
Martin Wilkinson
1 reference
Jain Chung
1 reference
Lynn Smiley
1 reference
Miklos Salgo
1 reference
1 February 2006
1 reference
1 reference
42
1 reference
870-877
1 reference
6
1 reference
Identifiers
1 reference
1 reference